Sol-Gel Technologies Ltd. Stock price
Is Sol-Gel Technologies Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Sol-Gel Technologies Ltd. Stock Analysis
Analyst Opinions
10 Analysts have issued a Sol-Gel Technologies Ltd. forecast:
Analyst Opinions
10 Analysts have issued a Sol-Gel Technologies Ltd. forecast:
Don't miss a Thing! We will send you all news about Sol-Gel Technologies Ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sol-Gel Technologies Ltd. Stock News
Company Profile
Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
| Head office | Israel |
| CEO | Moshe Arkin |
| Employees | 28 |
| Founded | 1997 |
| Website | www.sol-gel.com |


